Stock Market Outlook: 2026 Will Be Another Year of Turning Lemons Into Lemonade
By any objective measure, U.S. stocks have had a pretty spectacular year. Rising from the ashes of President Donald Trump’s Liberation Day tariffs like a phoenix.
BRIEF-Abbott Receives Regulatory Approval For The First Denosumab Biosimilar In Thailand
BRIEF-Abbott Receives Regulatory Approval For The First Denosumab Biosimilar In ThailandAug 26 (Reuters) - Abbott Laboratories ABT.N:ABBOTT RECEIVES REGULATORY APPROVAL FOR THE FIRST DENOSUMAB BIOSIMI